@steven49 the risk here now is can they raise the funding before they run out of money from the last DOID handout. If not they will give this to DOID on the cheap. Then game over for investors!
Crunch time for ARS simple as. The next placing to DOID will wipe out private retail investors and enable DOID take more of the company on the cheap. DOID are not far now from a 51% stake.
I'm afraid this is where most juniors fail. Raising $235 mil in this climate was a dream. They should accept the highest low ball offer they can get and call it a day.